Diagnosis and treatment of primary aldosteronism
Primary aldosteronism is a common cause of secondary hypertension associated with
excess cardiovascular morbidities. Primary aldosteronism is underdiagnosed because it …
excess cardiovascular morbidities. Primary aldosteronism is underdiagnosed because it …
Hypertension: do inflammation and immunity hold the key to solving this epidemic?
Elevated cardiovascular risk including stroke, heart failure, and heart attack is present even
after normalization of blood pressure in patients with hypertension. Underlying immune cell …
after normalization of blood pressure in patients with hypertension. Underlying immune cell …
[HTML][HTML] Diretrizes brasileiras de hipertensão arterial–2020
WKS Barroso, CIS Rodrigues, LA Bortolotto… - Arquivos brasileiros de …, 2021 - SciELO Brasil
A hipertensão arterial (HA) é uma doença crônica não transmissível (DCNT) definida por
níveis pressóricos, em que os benefícios do tratamento (não medicamentoso e/ou …
níveis pressóricos, em que os benefícios do tratamento (não medicamentoso e/ou …
[HTML][HTML] Brazilian guidelines of hypertension–2020
WKS Barroso, CIS Rodrigues, LA Bortolotto… - Arquivos brasileiros de …, 2021 - SciELO Brasil
SciELO - Brasil - Diretrizes Brasileiras de Hipertensão Arterial – 2020 Diretrizes Brasileiras de
Hipertensão Arterial – 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos …
Hipertensão Arterial – 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos …
[HTML][HTML] 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension
Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all-
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …
Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión-Liga Española para la Lucha contra …
M Gorostidi, T Gijón-Conde, A De la Sierra… - Hipertensión y riesgo …, 2022 - Elsevier
La hipertensión arterial es el principal factor de riesgo de enfermedad y muerte en España.
El diagnóstico y el tratamiento de la hipertensión arterial constituyen objetivos básicos de …
El diagnóstico y el tratamiento de la hipertensión arterial constituyen objetivos básicos de …
Endothelin: 30 years from discovery to therapy
M Barton, M Yanagisawa - Hypertension, 2019 - Am Heart Assoc
Discovered in 1987 as a potent endothelial cell–derived vasoconstrictor peptide, endothelin-
1 (ET-1), the predominant member of the endothelin peptide family, is now recognized as a …
1 (ET-1), the predominant member of the endothelin peptide family, is now recognized as a …
[HTML][HTML] Pathophysiology and genetics of salt-sensitive hypertension
Most hypertensive cases are primary and heavily associated with modifiable risk factors like
salt intake. Evidence suggests that even small reductions in salt consumption reduce blood …
salt intake. Evidence suggests that even small reductions in salt consumption reduce blood …
A review of systemic medications that may modulate the risk of glaucoma
A Wu, AP Khawaja, LR Pasquale, JD Stein - Eye, 2020 - nature.com
With increasing longevity, patients are developing more and more chronic diseases that
require treatment with medications. Yet, it is not fully understood the extent by which these …
require treatment with medications. Yet, it is not fully understood the extent by which these …
What is resistant arterial hypertension?
EV Shalaeva, FH Messerli - Blood pressure, 2023 - Taylor & Francis
Purpose The current review is to describe the definition and prevalence of resistant arterial
hypertension (RAH), the difference between refractory hypertension, patient characteristics …
hypertension (RAH), the difference between refractory hypertension, patient characteristics …